Jeffrey Bolton Buys 10,000 Shares of Enhabit, Inc. (NYSE:EHAB) Stock

Enhabit, Inc. (NYSE:EHABGet Free Report) Director Jeffrey Bolton acquired 10,000 shares of the stock in a transaction dated Friday, May 17th. The stock was acquired at an average price of $8.33 per share, for a total transaction of $83,300.00. Following the completion of the transaction, the director now directly owns 52,299 shares of the company’s stock, valued at $435,650.67. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Jeffrey Bolton also recently made the following trade(s):

  • On Friday, May 10th, Jeffrey Bolton bought 10,000 shares of Enhabit stock. The shares were acquired at an average price of $8.24 per share, with a total value of $82,400.00.

Enhabit Price Performance

Enhabit stock opened at $8.25 on Friday. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.50 and a current ratio of 1.50. Enhabit, Inc. has a twelve month low of $7.12 and a twelve month high of $14.59. The company’s 50-day moving average price is $10.34 and its 200-day moving average price is $10.07.

Enhabit (NYSE:EHABGet Free Report) last issued its quarterly earnings data on Wednesday, March 6th. The company reported $0.03 earnings per share for the quarter, topping the consensus estimate of $0.02 by $0.01. The company had revenue of $260.60 million for the quarter, compared to analysts’ expectations of $260.30 million. Enhabit had a positive return on equity of 1.43% and a negative net margin of 7.95%. During the same period in the previous year, the firm posted $0.32 earnings per share. Analysts predict that Enhabit, Inc. will post 0.24 earnings per share for the current year.

Institutional Trading of Enhabit

Several hedge funds and other institutional investors have recently bought and sold shares of EHAB. SummerHaven Investment Management LLC grew its position in Enhabit by 1.8% in the 4th quarter. SummerHaven Investment Management LLC now owns 58,947 shares of the company’s stock valued at $610,000 after acquiring an additional 1,038 shares during the last quarter. Brooks Moore & Associates Inc. boosted its position in Enhabit by 5.1% in the 3rd quarter. Brooks Moore & Associates Inc. now owns 26,950 shares of the company’s stock valued at $303,000 after buying an additional 1,300 shares during the period. Oppenheimer & Co. Inc. boosted its position in Enhabit by 7.2% in the 1st quarter. Oppenheimer & Co. Inc. now owns 26,224 shares of the company’s stock valued at $306,000 after buying an additional 1,768 shares during the period. PNC Financial Services Group Inc. grew its stake in Enhabit by 13.2% in the 4th quarter. PNC Financial Services Group Inc. now owns 16,058 shares of the company’s stock worth $166,000 after acquiring an additional 1,875 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD increased its position in shares of Enhabit by 5.8% during the first quarter. Price T Rowe Associates Inc. MD now owns 37,950 shares of the company’s stock worth $443,000 after acquiring an additional 2,078 shares during the period.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on EHAB shares. Leerink Partnrs raised shares of Enhabit from a “strong sell” rating to a “hold” rating in a report on Tuesday, May 14th. Oppenheimer reiterated a “market perform” rating on shares of Enhabit in a report on Thursday, March 7th. UBS Group raised shares of Enhabit from a “sell” rating to a “neutral” rating and set a $9.50 price objective for the company in a report on Thursday, March 7th. Jefferies Financial Group cut Enhabit from a “buy” rating to a “hold” rating and reduced their target price for the stock from $14.00 to $8.75 in a report on Thursday, May 9th. Finally, SVB Leerink raised Enhabit from an “underperform” rating to a “market perform” rating and set a $8.50 price target for the company in a research note on Tuesday, May 14th. One investment analyst has rated the stock with a sell rating and seven have assigned a hold rating to the stock. According to data from MarketBeat.com, Enhabit presently has an average rating of “Hold” and an average price target of $10.13.

Read Our Latest Analysis on EHAB

Enhabit Company Profile

(Get Free Report)

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

See Also

Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.